In 2000 GHB was easily available in New Zealand. On 1 April 2000 the media reported the first GHB fatality in New Zealand, and this was followed by numerous admissions to hospital of people with severe respiratory depression and coma after taking it. GHB and its related substances were scheduled as a Class B drug in May 2002 under the Misuse of Drugs Act 1975.